Athira Pharma, Inc. (ATHA) Reports In-Line Q2 EPS
Athira Pharma, Inc. (NASDAQ: ATHA) reported Q2 EPS of ($0.78), in-line with the analyst estimate of ($0.78).
For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.
Athira Pharma, Inc. (NASDAQ: ATHA) reported Q2 EPS of ($0.78), in-line with the analyst estimate of ($0.78).
For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.